valine has been researched along with midazolam in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Danielsen, P; Deacon, CF; Holst, JJ; Klarskov, L; Olesen, M | 1 |
Chang, SY; Cheng, Y; Humphreys, WG; Li, W; Ma, L | 1 |
2 other study(ies) available for valine and midazolam
Article | Year |
---|---|
Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs.
Topics: Anesthesia; Animals; Blood Glucose; Chromatography, High Pressure Liquid; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Insulin; Ketamine; Midazolam; Pyrroles; Radioimmunoassay; Swine; Valine | 2001 |
Application of Static Models to Predict Midazolam Clinical Interactions in the Presence of Single or Multiple Hepatitis C Virus Drugs.
Topics: Algorithms; Antiviral Agents; Benzazepines; Biotransformation; Carbamates; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Hepatitis C, Chronic; Hepatocytes; Humans; Imidazoles; Indoles; Isoquinolines; Kinetics; Liver; Midazolam; Models, Biological; Nonlinear Dynamics; Pyrrolidines; Risk Assessment; Risk Factors; RNA, Messenger; Sulfonamides; Valine | 2016 |